Anfield Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $109K | Hold |
|
|||||
|
2025
Q2 | $65.5K | Hold |
|
|||||
|
2025
Q1 | $63.1K | Hold |
|
|||||
|
2024
Q4 | $120K | Hold |
|
|||||
|
2024
Q3 | $123K | Hold |
|
|||||
|
2024
Q2 | $122K | Hold |
|
|||||
|
2024
Q1 | $152K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $11K | Sell |
|
|||||
|
2022
Q3 | $210K | Hold |
|
|||||
|
2022
Q2 | $204K | Hold |
|
|||||
|
2022
Q1 | $254K | Hold |
|
|||||
|
2021
Q4 | $325K | Hold |
|
|||||
|
2021
Q3 | $275K | Hold |
|
|||||
|
2021
Q2 | $221K | Hold |
|
|||||
|
2021
Q1 | $226K | Hold |
|
|||||
|
2020
Q4 | $209K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $76K | Buy |
|